Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Increased microRNA-630 expression in gastric cancer is associated with poor overall survival.

Chu D, Zhao Z, Li Y, Li J, Zheng J, Wang W, Zhao Q, Ji G.

PLoS One. 2014 Mar 12;9(3):e90526. doi: 10.1371/journal.pone.0090526. eCollection 2014.

PMID:
24621930
[PubMed - in process]
Free PMC Article
2.

MicroRNA-630 is a prognostic marker for patients with colorectal cancer.

Chu D, Zheng J, Li J, Li Y, Zhang J, Zhao Q, Wang W, Ji G.

Tumour Biol. 2014 Jul 1. [Epub ahead of print]

PMID:
24981248
[PubMed - as supplied by publisher]
3.

The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis.

Li X, Yang C, Wang X, Zhang J, Zhang R, Liu R.

Med Oncol. 2014 Jan;31(1):781. doi: 10.1007/s12032-013-0781-7. Epub 2013 Nov 29.

PMID:
24293092
[PubMed - in process]
4.

Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.

Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R.

Oncol Rep. 2012 Jun;27(6):1759-64. doi: 10.3892/or.2012.1709. Epub 2012 Mar 7.

PMID:
22407237
[PubMed - indexed for MEDLINE]
5.

Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival.

Zhao JJ, Chen PJ, Duan RQ, Li KJ, Wang YZ, Li Y.

Int J Clin Exp Pathol. 2014 May 15;7(6):3318-23. eCollection 2014.

PMID:
25031755
[PubMed - in process]
Free PMC Article
6.

Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.

Yang Q, Zhang C, Huang B, Li H, Zhang R, Huang Y, Wang J.

Eur J Gastroenterol Hepatol. 2013 Aug;25(8):953-7. doi: 10.1097/MEG.0b013e32835ed691.

PMID:
23751352
[PubMed - indexed for MEDLINE]
7.

MicroRNA-148b expression is decreased in hepatocellular carcinoma and associated with prognosis.

Zhang Z, Zheng W, Hai J.

Med Oncol. 2014 Jun;31(6):984. doi: 10.1007/s12032-014-0984-6. Epub 2014 May 8.

PMID:
24805877
[PubMed - in process]
8.

Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer.

Shen SN, Wang LF, Jia YF, Hao YQ, Zhang L, Wang H.

Diagn Pathol. 2013 Apr 30;8:69. doi: 10.1186/1746-1596-8-69.

PMID:
23631806
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.

Zhou T, Zhang G, Liu Z, Xia S, Tian H.

Int J Colorectal Dis. 2013 Jan;28(1):19-24. doi: 10.1007/s00384-012-1528-1. Epub 2012 Jul 7.

PMID:
22772712
[PubMed - indexed for MEDLINE]
10.

Prognostic significance of microRNA-16 expression in human colorectal cancer.

Qian J, Jiang B, Li M, Chen J, Fang M.

World J Surg. 2013 Dec;37(12):2944-9. doi: 10.1007/s00268-013-2205-4.

PMID:
24045965
[PubMed - in process]
11.

Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.

Hashiguchi Y, Nishida N, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Mochizuki H, Hase K, Doki Y, Mori M.

Int J Oncol. 2012 May;40(5):1477-82. doi: 10.3892/ijo.2012.1363. Epub 2012 Feb 9.

PMID:
22322911
[PubMed - indexed for MEDLINE]
12.

Matrilysin-2 expression in colorectal cancer is associated with overall survival of patients.

Hu Q, Yan C, Xu C, Yan H, Qing L, Pu Y, He Z, Li X.

Tumour Biol. 2014 Apr;35(4):3569-74. doi: 10.1007/s13277-013-1471-y. Epub 2013 Dec 8.

PMID:
24318970
[PubMed - indexed for MEDLINE]
13.

microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN.

Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M.

Oncol Rep. 2012 Apr;27(4):1019-26. doi: 10.3892/or.2012.1645. Epub 2012 Jan 19.

PMID:
22267008
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.

Zhou T, Zhang GJ, Zhou H, Xiao HX, Li Y.

Eur J Gastroenterol Hepatol. 2014 Feb;26(2):229-33. doi: 10.1097/MEG.0000000000000002.

PMID:
24150523
[PubMed - in process]
15.

Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer.

Xu T, Liu X, Han L, Shen H, Liu L, Shu Y.

Clin Transl Oncol. 2014 May;16(5):469-75. doi: 10.1007/s12094-013-1106-1. Epub 2013 Sep 10.

PMID:
24019037
[PubMed - in process]
16.

Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.

Yang J, Liu H, Wang H, Sun Y.

Pathol Res Pract. 2013 Aug;209(8):490-4. doi: 10.1016/j.prp.2013.04.018. Epub 2013 Jun 6.

PMID:
23827213
[PubMed - indexed for MEDLINE]
17.

MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1.

Xu Y, Zhao F, Wang Z, Song Y, Luo Y, Zhang X, Jiang L, Sun Z, Miao Z, Xu H.

Oncogene. 2012 Mar 15;31(11):1398-407. doi: 10.1038/onc.2011.340. Epub 2011 Aug 8.

PMID:
21822301
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma.

Kim BH, Hong SW, Kim A, Choi SH, Yoon SO.

J Surg Oncol. 2013 Apr;107(5):505-10. doi: 10.1002/jso.23271. Epub 2012 Sep 20.

PMID:
22996433
[PubMed - indexed for MEDLINE]
19.

Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.

Liu K, Li G, Fan C, Diao Y, Wu B, Li J.

J Int Med Res. 2012;40(2):467-74.

PMID:
22613407
[PubMed - indexed for MEDLINE]
20.

Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis.

Wang W, Li F, Zhang Y, Tu Y, Yang Q, Gao X.

Diagn Pathol. 2013 Jun 21;8:102. doi: 10.1186/1746-1596-8-102.

PMID:
23786758
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk